Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006 by University of Oslo.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00204165
First received: September 13, 2005
Last updated: September 7, 2006
Last verified: September 2006
  Purpose

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.


Condition Intervention Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
Procedure: MRI of the small bowel
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Resource links provided by NLM:


Further study details as provided by University of Oslo:

Estimated Enrollment: 40
Study Start Date: November 2004
Estimated Study Completion Date: June 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • above 18 years
  • known Crohns disease or strong suspicion.
  • need of a small bowel examination

Exclusion Criteria:

  • pregnant
  • electrolyte disturbances.
  • Any MRI contraindications.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204165

Locations
Norway
Ulleval Universitets sykehus
Kirkeveien 166, Oslo, Norway, 0407
Sponsors and Collaborators
University of Oslo
Investigators
Study Director: Nils-Einar Kløw, Prof. MD Ulleval Universitetssykehus
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00204165     History of Changes
Other Study ID Numbers: 431-04150
Study First Received: September 13, 2005
Last Updated: September 7, 2006
Health Authority: Norway: Directorate of Health

Additional relevant MeSH terms:
Crohn Disease
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases

ClinicalTrials.gov processed this record on November 19, 2014